Back to search

Spain· ES:88677

DUODOPA 240 MG/ML + 12 MG/ML SOLUCION PARA PERFUSION

A medicinal product containing foslevodopa + foscarbidopa, registered in Spain by Abbvie Spain, S.L.U..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedDUODOPA 240 MG/ML + 12 MG/ML SOLUCION…ATC—REGISTER NO.ES:88677PACKS LISTED0CHECKEDSeptember 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
foslevodopa + foscarbidopa
Manufacturer
Abbvie Spain, S.L.U.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Foslevodopa + foscarbidopa in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All foslevodopa + foscarbidopa products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Produodopa
  • Belgium · Produodopa
  • Bulgaria · Продуодопа
  • Cyprus · Produodopa
  • Czechia · Duodopa Sc
  • Germany · Produodopa®
  • Denmark · Duodopa
  • Estonia · Produodopa
  • Finland · Produodopa
  • France · Scyova
  • Greece · Produodopa
  • Croatia · Produodopa
  • Hungary · Produodopa
  • Ireland · Produodopa
  • Iceland · Produodopa
  • Italy · Duodopa
  • Liechtenstein · Produodopa
  • Lithuania · Duodopa
  • Luxembourg · Produodopa
  • Netherlands · Duodopa
  • Norway · Produodopa
  • Poland · Produodopa
  • Portugal · Duodopa
  • Romania · Produodopa
  • Sweden · Produodopa
  • Slovenia · Produodopa
  • Slovakia · Duodopa Sc

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f88bc118-3a1a-4baa-93b7-50c5595ef094
GET /v1/drugs/f88bc118-3a1a-4baa-93b7-50c5595ef094?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Uso Hospitalario",
  "estado": "{\"aut\":1676906302000}",
  "nregistro": "88677",
  "substance": "foslevodopa + foscarbidopa"
}

See everything about foslevodopa + foscarbidopa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.